Europe Biosimilars Market Size, Share, Forecast, and Growth Opportunity
Europe biosimilars market was valued at $5,847.6 million in 2020 and will grow by 23.1% annually over 2020-2030 owing to the affordability of biosimilar-based treatment, rising incidence of chronic diseases due to aging populations, patent expirations of many blockbuster drugs, and better healthcare provisions.Highlighted with 37 tables and 57 figures, this 121-page report “Europe Biosimilars … Read more